Bloomberg BusinessweekBloomberg Businessweek

Ozempic’s Success Is Bad News for Rivals

View descriptionShare

Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Bloomberg Businessweek

    4,347 clip(s)

Bloomberg Businessweek

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance  
Social links
Follow podcast
Recent clips
Browse 4,350 clip(s)